Verified Peptide ReviewLast reviewed: 10 April 2026
Compound Profile · Longevity
FOXO4-DRI
FOXO4-DRI is a cell-penetrating peptide designed to disrupt FOXO4 interaction, studied in research models for senescence and aging.
LegalResearch onlyEvidenceEmergingHuman useNot approved
6.0/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Mechanistically interesting senescence-targeting peptide. Human research is very early-stage.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Evidence base is early — long-term data limited
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full FOXO4-DRI review
A cell-penetrating peptide designed as a FOXO4 inhibitor.
Studied for senescent cell clearance in aging research.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.